LUTHERVILLE, Md., April 17, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest quarterly results achieved by the real-time, stop-sale system in Florida. Data released for the first quarter of the year by the National Precursor Log Exchange (NPLEx) shows electronic technology in the Sunshine State blocked the sale of more than 34,700 boxes of medicines containing pseudoephedrine (PSE) preventing more than 87,600 grams from potentially being diverted by meth criminals.
"Florida's real-time, stop-sale system continues to yield impressive results," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "NPLEx is an exciting new tool for Florida that allows retailers - in a process akin to a credit card transaction - to block illegal purchases of common medications containing pseudoephedrine right at the point of sale. NPLEx data, which often shows clear trends in criminal behavior, is also provided to law enforcement through a variety of sources in real time. This targeted approach allows Florida officials to focus on the criminals who are the cause of the meth problem and protect responsible Floridians' access to the medicines they depend on for relief from cold and allergy symptoms."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators